Greensignal Bio Pharma
No trades in 1Y
Key Insights
Strengths
1- Debtor days have improved from 204 to 23.6 days.
Weaknesses
1- Company has low interest coverage ratio.
Growth Rate
From the financial statements below. 5Y, 3Y: compound annual growth to Mar 2025; 1Y: fiscal year to Mar 2025 against Mar 2024.
Revenue
| 5Y | +13.97% |
|---|---|
| 3Y | +24.36% |
| 1Y | 0.00% |
Net profit
| 5Y | Loss widened by ₹28 Cr |
|---|---|
| 3Y | Loss widened by ₹17 Cr |
| 1Y | Loss narrowed by ₹4 Cr |
Operating cash flow
| 5Y | Outflow narrowed by ₹10 Cr |
|---|---|
| 3Y | Outflow narrowed by ₹25 Cr |
| 1Y | Outflow narrowed by ₹122 Cr |
Operating margin· change in pp
| 5Y | −68.92 pp |
|---|---|
| 3Y | −53.54 pp |
| 1Y | −12.00 pp |
Trailing twelve months: No quarterly results are reported.
Revenue by year
| Mar 2017 | ₹27.00 Cr |
|---|---|
| Mar 2018 | ₹30.00 Cr |
| Mar 2019 | ₹29.00 Cr |
| Mar 2020 | ₹13.00 Cr |
| Mar 2021 | ₹28.00 Cr |
| Mar 2022 | ₹13.00 Cr |
| Mar 2024 | ₹25.00 Cr |
| Mar 2025 | ₹25.00 Cr |
Net profit by year
| Mar 2017 | ₹4.00 Cr |
|---|---|
| Mar 2018 | ₹3.00 Cr |
| Mar 2019 | ₹10.00 Cr |
| Mar 2020 | −₹4.00 Cr |
| Mar 2021 | ₹5.00 Cr |
| Mar 2022 | −₹15.00 Cr |
| Mar 2024 | −₹36.00 Cr |
| Mar 2025 | −₹32.00 Cr |
Profit & Loss
₹ Cr| Particulars | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Sales | 27 | 30 | 29 | 13 | 28 | 13 | 25 | 25 |
| Expenses | 19 | 23 | 15 | 16 | 19 | 18 | 45 | 48 |
| Operating Profit | 8 | 7 | 14 | −3 | 9 | −5 | −20 | −23 |
| OPM % | 31% | 23% | 49% | −22% | 31% | −37% | −78% | −90% |
| Other Income | 0 | 0 | 2 | 2 | 0 | −4 | 0 | 1 |
| Interest | 1 | 0 | 0 | 0 | 0 | 0 | 7 | 1 |
| Depreciation | 3 | 3 | 3 | 3 | 3 | 4 | 8 | 8 |
| PBT | 6 | 4 | 13 | −4 | 6 | −13 | −34 | −31 |
| Tax % | 37% | 29% | 24% | 2% | 16% | 19% | 6% | 4% |
| Net Profit | 4 | 3 | 10 | −4 | 5 | −15 | −36 | −32 |
| EPS (₹) | 0.93 | 0.76 | 2.59 | −1.12 | 1.4 | −3.96 | −9.37 | −8.37 |
| Div. Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Balance Sheet
₹ Cr| Particulars | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Equity Capital | 38 | 38 | 38 | 38 | 38 | 38 | 38 | 38 |
| Reserves | 11 | 13 | 23 | 18 | 24 | 9 | −57 | −89 |
| Borrowings | 3 | 0 | 0 | 0 | 48 | 108 | 256 | 341 |
| Other Liabilities | 6 | 7 | 7 | 7 | 9 | 9 | 39 | 29 |
| Total Liabilities | 58 | 58 | 68 | 63 | 119 | 164 | 276 | 319 |
| Fixed Assets | 39 | 35 | 33 | 31 | 28 | 58 | 117 | 121 |
| CWIP | 0 | 0 | 0 | 0 | 45 | 45 | 46 | 102 |
| Investments | 0 | 8 | 12 | 0 | 0 | 2 | 0 | 1 |
| Other Assets | 19 | 16 | 22 | 32 | 46 | 59 | 113 | 95 |
| Total Assets | 58 | 58 | 68 | 63 | 119 | 164 | 276 | 319 |
Cash Flow
₹ Cr| Particulars | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating | −1 | 12 | 4 | −11 | −2 | −26 | −123 | −1 |
| Investing | −3 | 1 | −2 | 0 | −42 | −34 | −21 | −65 |
| Financing | 0 | 3 | −5 | 12 | 48 | 59 | 142 | 74 |
| Net Cash Flow | −4 | 16 | −2 | 1 | 5 | 0 | −2 | 7 |
| Free Cash Flow | −4 | 14 | 3 | −11 | −2 | −59 | −141 | −13 |
| CFO/OP | 13 | 189 | 31 | 375 | −18 | 532 | 630 | 6 |
Ratios
| Particulars | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Debtor Days | 64 | 34 | 85 | 129 | 92 | 1 | 384 | 24 |
| Inventory Days | 548 | 113 | 551 | 404 | 255 | 259 | 356 | 382 |
| Days Payable | 97 | 63 | 69 | 50 | 81 | 79 | 674 | 357 |
| Cash Conversion Cycle | 515 | 85 | 567 | 482 | 267 | 180 | 65 | 48 |
| Working Capital Days | 151 | 75 | 188 | 668 | 455 | 1,384 | 1,156 | 826 |
| ROCE % | — | 9% | 24% | −7% | 8% | −6% | — | −11% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Greensignal Bio Pharma insights
29 extracted metrics across FY17–FY25.
Frequently Asked Questions about Greensignal Bio Pharma
What does Greensignal Bio Pharma Ltd do?
Company Information
Greensignal Bio Pharma Limited was incorporated on 21st November 2005 as a Private Limited Company. The Company changed its name to GreenSignal Bio Pharma Private Limited on 21st April 2016. The Company has been converted into Public Limited Company consequent to issue of revised Certificate of Incorporation dated 12th May 2016 by the Registrar of Companies. The Company has been converted into Private Limited Company consequent to issue of revised Certificate of Incorporation dated 29th December 2017 by the Registrar of Companies. The Company produces Life Saving Vaccine, namely, BCG Vaccine.
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/1275414.md for Greensignal Bio Pharma Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.
Append .md to any Tapetide URL for
the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.